Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | METAP2 | P50579 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13633458 | 0.88 | KDM4E (0.49) | KDM4EALDH1A1LMNAGAAPKM | |
| SCHEMBL13633551 | 0.78 | ALDH1A1 (0.53) | KDM4EALDH1A1LMNAGAASMN1; SMN2 | |
| SCHEMBL13633538 | 0.77 | METAP2 (0.54) | KDM4EALDH1A1LMNAGAAPKM | |
| SCHEMBL13633501 | 0.74 | KDM4E (0.58) | KDM4EALDH1A1LMNASMN1; SMN2HTT | |
| SCHEMBL13749029 | 0.72 | KDM4E (0.49) | KDM4EALDH1A1LMNAGAAPKM | |
| SCHEMBL13749526 | 0.70 | ALDH1A1 (0.44) | KDM4EALDH1A1LMNAGAAPKM | |
| SCHEMBL9662788 | 0.70 | CYP2C9 (0.48) | ALDH1A1LMNAGAAPKMHSD11B1 | |
| SCHEMBL3146296 | 0.70 | KDM4E (0.58) | KDM4EALDH1A1LMNAHSD11B1SMN1; SMN2 | |
| SCHEMBL14908004 | 0.70 | KDM4E (0.68) | KDM4EALDH1A1LMNAGAAPKM | |
| SCHEMBL3006653 | 0.70 | HSD11B1 (0.67) | KDM4EALDH1A1LMNAHSD11B1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7563788-B2 | Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents | PFIZER INC. (US) | 2009-07-21 | — | — | US | disclosed |
| US-20070191394-A1 | Antibacterial agents | WARNER-LAMBERT COMPANY LLC | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191394-A1 | Antibacterial agents | MRPL21, RPN2, FBL | KDM4E 4500/4885ALDH1A1 637/4885LMNA 2919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.